239 related articles for article (PubMed ID: 17507800)
21. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
22. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
23. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-encoded latent membrane protein 1 promotes stress-induced apoptosis upstream of caspase-2-dependent mitochondrial perturbation.
Zhang X; Uthaisang W; Hu L; Ernberg IT; Fadeel B
Int J Cancer; 2005 Jan; 113(3):397-405. PubMed ID: 15455353
[TBL] [Abstract][Full Text] [Related]
25. Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
Yang L; Xu Z; Liu L; Luo X; Lu J; Sun L; Cao Y
Cancer Biol Ther; 2014 Jan; 15(1):61-8. PubMed ID: 24145206
[TBL] [Abstract][Full Text] [Related]
26. Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
Hau PM; Tsang CM; Yip YL; Huen MS; Tsao SW
PLoS One; 2011; 6(6):e21176. PubMed ID: 21701587
[TBL] [Abstract][Full Text] [Related]
27. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
28. Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Endo K; Nakanishi Y; Aga M; Kobayashi E; Hirai N; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Wakisaka N
Cancer Sci; 2018 Feb; 109(2):272-278. PubMed ID: 29247573
[TBL] [Abstract][Full Text] [Related]
29. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
30. Modulation of LMP1 protein expression by EBV-encoded microRNAs.
Lo AK; To KF; Lo KW; Lung RW; Hui JW; Liao G; Hayward SD
Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16164-9. PubMed ID: 17911266
[TBL] [Abstract][Full Text] [Related]
31. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.
Yang CF; Yang GD; Huang TJ; Li R; Chu QQ; Xu L; Wang MS; Cai MD; Zhong L; Wei HJ; Huang HB; Huang JL; Qian CN; Huang BJ
Oncogene; 2016 Jun; 35(26):3419-31. PubMed ID: 26568302
[TBL] [Abstract][Full Text] [Related]
32. LMP1 strain variants: biological and molecular properties.
Mainou BA; Raab-Traub N
J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
[TBL] [Abstract][Full Text] [Related]
33. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.
Wang Z; Xie J; Yan M; Wang J; Wang X; Zhang J; Zhang Y; Li P; Lei X; Huang Q; Lin S; Guo X; Liu Q
Oncotarget; 2016 May; 7(18):26765-79. PubMed ID: 27049918
[TBL] [Abstract][Full Text] [Related]
35. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.
Chen J; Hu CF; Hou JH; Shao Q; Yan LX; Zhu XF; Zeng YX; Shao JY
J Transl Med; 2010 Mar; 8():30. PubMed ID: 20338061
[TBL] [Abstract][Full Text] [Related]
37. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.
Chan KC; Ting CM; Chan PS; Lo MC; Lo KW; Curry JE; Smyth T; Lee AW; Ng WT; Tsao GS; Wong RN; Lung ML; Mak NK
Mol Cancer; 2013 Oct; 12(1):128. PubMed ID: 24156782
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.
Ma L; Deng X; Wu M; Zhang G; Huang J
FEBS Lett; 2014 May; 588(9):1562-70. PubMed ID: 24613926
[TBL] [Abstract][Full Text] [Related]
39. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma.
Zhao Y; Pang TY; Wang Y; Wang S; Kang HX; Ding WB; Yong WW; Bie YH; Cheng XG; Zeng C; Yao YH; Li Q; Hu XR
FEBS J; 2014 Jul; 281(13):3004-18. PubMed ID: 24814906
[TBL] [Abstract][Full Text] [Related]
40. EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling.
Liu H; Duan Z; Zheng H; Hu D; Li M; Tao Y; Bode AM; Dong Z; Cao Y
PLoS One; 2012; 7(3):e32624. PubMed ID: 22396784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]